Berglund MM - Search Results

1

Combined Inhibition of C5 and CD14 Attenuates Systemic Inflammation in a Piglet Model of Meconium Aspiration Syndrome.

Thomas AM, Schjalm C, Nilsson PH, Lindenskov PHH, Rørtveit R, Solberg R, Saugstad OD, Berglund MM, Strömberg P, Lau C, Espevik T, Jansen JH, Castellheim A, Mollnes TE, Barratt-Due A. Thomas AM, et al. Among authors: berglund mm. Neonatology. 2018;113(4):322-330. doi: 10.1159/000486542. Epub 2018 Feb 27. Neonatology. 2018. PMID: 29486477 Free PMC article.

2

The clinical potential of Affibody-based inhibitors of C5 for therapeutic complement disruption.

Berglund MM, Strömberg P. Berglund MM, et al. Expert Rev Proteomics. 2016;13(3):241-3. doi: 10.1586/14789450.2016.1148604. Expert Rev Proteomics. 2016. PMID: 26837283 No abstract available.

3

Stratification of responders towards eculizumab using a structural epitope mapping strategy.

Volk AL, Hu FJ, Berglund MM, Nordling E, Strömberg P, Uhlen M, Rockberg J. Volk AL, et al. Among authors: berglund mm. Sci Rep. 2016 Aug 11;6:31365. doi: 10.1038/srep31365. Sci Rep. 2016. PMID: 27509843 Free PMC article.

4

The blood endothelial cell chamber - An innovative system to study immune responses in drug development.

Stančič B, Qvarfordt B, Berglund MM, Brenden N, Sydow Bäckman M, Fransson M, Nordling S, Magnusson PU. Stančič B, et al. Among authors: berglund mm. Int Immunopharmacol. 2021 Jan;90:107237. doi: 10.1016/j.intimp.2020.107237. Epub 2020 Dec 11. Int Immunopharmacol. 2021. PMID: 33310662 Free article.

5

A truncated analogue of CCL2 mediates anti-fibrotic effects on murine fibroblasts independently of CCR2.

Kalderén C, Forsgren M, Karlström U, Stefansson K, Svensson R, Berglund MM, Palm G, Selander M, Sundbom M, Nilsson J, Sjögren A, Zachrisson K, Gelius SS. Kalderén C, et al. Among authors: berglund mm. Biochem Pharmacol. 2012 Mar 1;83(5):644-52. doi: 10.1016/j.bcp.2011.12.001. Epub 2011 Dec 9. Biochem Pharmacol. 2012. PMID: 22177985

6

Binding properties of three neuropeptide Y receptor subtypes from zebrafish: comparison with mammalian Y1 receptors.

Berglund MM, Lundell I, Cabrele C, Serradeil-Le Gal C, Beck-Sickinger AG, Larhammar D. Berglund MM, et al. Biochem Pharmacol. 2000 Dec 15;60(12):1815-22. doi: 10.1016/s0006-2952(00)00502-5. Biochem Pharmacol. 2000. PMID: 11108796

7

Discovery of a potent and long-acting bronchorelaxing capsazepinoid, RESPIR 4-95.

Skogvall S, Dalence-Guzmán MF, Berglund M, Svensson K, Mesic A, Jönsson P, Persson CG, Sterner O. Skogvall S, et al. Pulm Pharmacol Ther. 2008;21(1):125-33. doi: 10.1016/j.pupt.2007.01.004. Epub 2007 Feb 12. Pulm Pharmacol Ther. 2008. PMID: 17374498

8

Re-evaluation of receptor-ligand interactions of the human neuropeptide Y receptor Y1: a site-directed mutagenesis study.

Sjödin P, Holmberg SK, Akerberg H, Berglund MM, Mohell N, Larhammar D. Sjödin P, et al. Among authors: berglund mm. Biochem J. 2006 Jan 1;393(Pt 1):161-9. doi: 10.1042/BJ20050708. Biochem J. 2006. PMID: 16097949 Free PMC article.

9

Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.

Gehlert DR, Schober DA, Morin M, Berglund MM. Gehlert DR, et al. Among authors: berglund mm. Biochem Pharmacol. 2007 Dec 3;74(11):1652-64. doi: 10.1016/j.bcp.2007.08.017. Epub 2007 Aug 19. Biochem Pharmacol. 2007. PMID: 17897631

10

Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants.

Skogvall S, Berglund M, Dalence-Guzmán MF, Svensson K, Jönsson P, Persson CG, Sterner O. Skogvall S, et al. Pulm Pharmacol Ther. 2007;20(3):273-80. doi: 10.1016/j.pupt.2006.03.002. Epub 2006 May 30. Pulm Pharmacol Ther. 2007. PMID: 16731017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters